COPS7B expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.069800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.611970E-01
Normal-vs-Stage2
4.749400E-01
Normal-vs-Stage3
1.921350E-01
Normal-vs-Stage4
9.971600E-01
Stage1-vs-Stage2
6.091600E-01
Stage1-vs-Stage3
3.132800E-01
Stage1-vs-Stage4
1.737240E-01
Stage2-vs-Stage3
1.275840E-01
Stage2-vs-Stage4
4.139000E-01
Stage3-vs-Stage4
1.563580E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.159000E-01
Normal-vs-AfricanAmerican
3.714000E-01
Normal-vs-Asian
8.104800E-01
Caucasian-vs-AfricanAmerican
6.023800E-01
Caucasian-vs-Asian
2.737000E-01
AfricanAmerican-vs-Asian
2.633600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.927000E-01
Normal-vs-Female
4.382800E-01
Male-vs-Female
8.420600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.627000E-01
Normal-vs-Age(41-60Yrs)
7.443800E-01
Normal-vs-Age(61-80Yrs)
2.864600E-01
Normal-vs-Age(81-100Yrs)
2.704600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.972600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.408200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.863400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.082010E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.332800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.632600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.922200E-01
Normal-vs-Daily Drinker
5.245000E-01
Normal-vs-Weekly Drinker
5.783000E-01
Normal-vs-Occasional Drinker
4.076600E-01
Normal-vs-Social Drinker
6.939200E-01
Non Drinker-vs-Daily Drinker
6.431600E-01
Non Drinker-vs-Weekly Drinker
5.302600E-01
Non Drinker-vs-Occasional Drinker
5.251000E-01
Non Drinker-vs-Social Drinker
5.161800E-01
Daily Drinker-vs-Weekly Drinker
7.849000E-01
Daily Drinker-vs-Occasional Drinker
9.148000E-01
Daily Drinker-vs-Social Drinker
7.648000E-01
Weekly Drinker-vs-Occasional Drinker
8.267000E-01
Weekly Drinker-vs-Social Drinker
9.604200E-01
Occasional Drinker-vs-Social Drinker
8.199600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.669230E-01
Normal-vs-Grade 2
1.803970E-02
Normal-vs-Grade 3
6.730000E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.521620E-02
Grade 1-vs-Grade 3
2.883600E-02
Grade 1-vs-Grade 4
1.669230E-01
Grade 2-vs-Grade 3
5.490200E-01
Grade 2-vs-Grade 4
1.803970E-02
Grade 3-vs-Grade 4
6.730000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.070200E-01
Normal-vs-NonDiabetic
5.752000E-01
Diabetic-vs-NonDiabetic
3.533600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.038400E-01
Normal-vs-NoPancreatitis
3.263800E-01
Pancreatitis-vs-NoPancreatitis
2.156600E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.411200E-01
Normal-vs-N1
4.306600E-01
N0-vs-N1
9.751600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.527600E-01
Normal-vs-TP53-NonMutant
2.367400E-01
TP53-Mutant-vs-TP53-NonMutant
3.71379999997146E-06
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
